Skip to main content

Table 5 Clinical outcomes according to disease characteristics

From: Current management of patients hospitalized with community-acquired pneumonia across Europe: outcomes from REACH

Outcome

Type of CAP

Recurrence

Comorbidities

Severity

PORT/PSI risk score

CURB-65 risk groups

 

CAP only (n = 1,607)

HCAP (n = 245)

Immuno-compromised/immuno-suppressed (n = 72)

With (n = 94)

Without (n = 1,548)

With (n = 1,598)

Without (n = 441)

I (n = 18)

II (n = 53)

III (n = 83)

IV (n = 148)

V (n = 52)

Mild (0–1) (n = 154)

Moderate (2) (n = 185)

Severe (3–5) (n = 176)

Initial antibiotic treatment modification, n (%)

456 (28.4)

78 (31.8)

29 (40.3)

32 (34.0)

409 (26.4)

473 (29.6)

116 (26.3)

6 (33.3)

15 (28.3)

19 (22.9)

42 (28.4)

19 (36.5)

37 (24.0)

47 (25.4)

55 (31.3)

Streamlining, n (%)

72 (4.5)

21 (8.6)

9 (12.5)

8 (8.5)

82 (5.3)

84 (5.3)

21 (4.8)

0

4 (7.5)

6 (7.2)

6 (4.1)

4 (7.7)

4 (2.6)

7 (3.8)

6 (3.4)

Reinfection/recurrence, n (%)

70 (4.4)

16 (6.5)

5 (6.9)

94 (100)

0

88 (5.5)

6 (1.4)

0

2 (3.8)

4 (4.8)

9 (6.1)

5 (9.6)

2 (1.3)

11 (5.9)

12 (6.8)

Length of stay, days, median

9.0 (n = 1,558)

10.0 (n = 235)

12.0 (n = 71)

11.0 (n = 94)

9.0 (n = 1,548)

10.0 (n = 1,555)

8.0 (n = 423)

8.0 (n = 18)

8.0 (n = 53)

10.0 (n = 80)

10.0 (n = 148)

13.0 (n = 51)

8.0 (n = 153)

9.5 (n = 180)

10.0 (n = 175)

Time to clinical stability, days, median

4.0 (n = 1,284)

4.0 (n = 182)

5.0 (n = 55)

5.0 (n = 78)

4.0 (n = 1,295)

4.0 (n = 1,258)

4.0 (n = 345)

3.5 (n = 18)

3.0 (n = 43)

4.0 (n = 63)

5.0 (n = 139)

7.0 (n = 40)

4.0 (n = 137)

5.0 (n = 156)

5.0 (n = 142)

Mortality rate, n (%)

89 (5.5)

40 (16.3)

7 (9.7)

1 (1.1)

1 (0.1)

128 (8.0)

19 (4.3)

0

1 (1.9)

7 (8.4)

6 (4.1)

11 (21.2)

6 (3.9)

12 (6.5)

29 (16.5)

  1. CAP: community-acquired pneumonia; HCAP: healthcare-associated pneumonia; PORT/PSI: Pneumonia Outcomes Research Team/Pneumonia Severity Index; SD: standard deviation.